Advertisement

Laser and Scars

  • Giovanni Cannarozzo
  • Steven Paul Nisticò
  • Keyvan Nouri
  • Mario Sannino
Chapter
  • 84 Downloads

Abstract

Treatment of abnormal scars, such as hypertrophic scars, vascularized hypertrophic scars, keloids, post-acne scars, and atrophic scars, consists of various therapies (intralesional corticosteroids, interferon, topical retinoids, excisional surgery, etc.). Treatments by laser systems such as 10,600-nm ablative CO2 laser, 10,600-nm fractional microablative CO2 laser, 595-nm pulsed dye laser (PDL), and near- and medium-infrared sources, however, are very effective.

Notes

Acknowledgments

Special thanks to Dr. Luigi Bennardo, Dr. Giuseppe Lodi and Dr. Francesca Negosanti for their precious contribution in editing and revising this chapter.

References

  1. 1.
    Sund B. New developments in wound care, vol. 1. London: PJB Publications; 2000, p. 255.Google Scholar
  2. 2.
    Terrinoni A, Codispoti A, Serra V, Bruno E, Didona B, Paradisi M, Nisticò S, Campione E, Napolitano B, Diluvio L, Melino G. Connexin 26 (GJB2) mutations as a cause of the KID syndrome with hearing loss. Biochem Biophys Res Commun. 2010;395(1):25–30.  https://doi.org/10.1016/j.bbrc.2010.03.098.CrossRefPubMedGoogle Scholar
  3. 3.
    Paolillo N, Piccirilli S, Giardina E, Rispoli V, Colica C, Nisticò S. Effects of paraquat and capsaicin on the expression of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes. Int J Immunopathol Pharmacol. 2011;24(4):861–8.  https://doi.org/10.1177/039463201102400405.CrossRefPubMedGoogle Scholar
  4. 4.
    Nistico S, Tamburi F, Bennardo L, Dastoli S, Schipani G, Caro G, Fortuna MC, Rossi A. Treatment of telogen effluvium using a dietary supplement containing Boswellia serrata, Curcuma longa, and Vitis vinifera: Results of an observational study. Dermatol Ther. 2019;32(3):e12842.  https://doi.org/10.1111/dth.12842.CrossRefPubMedGoogle Scholar
  5. 5.
    Muscoli C, Lauro F, Dagostino C, Ilari S, Giancotti LA, Gliozzi M, Costa N, Carresi C, Musolino V, Casale F, Ventrice D, Oliverio E, Palma E, Nisticò S, Procopio A, Mollace V. Olea europea-derived phenolic products attenuate antinociceptive morphine tolerance: an innovative strategic approach to treat cancer pain. J Biol Reg Homeost Ag. 2014;28(1):105–16.Google Scholar
  6. 6.
    Chiricozzi A, Saraceno R, Nisticò SP, Chimenti S, Giunta A. Complete resolution of erythrodermic psoriasis in a HIV and HCV patient unresponsive to anti-psoriatic treatments after highly active anti-retroviral therapy (ritonavir, atenzanavir, emtricitabine, tenofovir). Dermatology. 2012;225(4):333–7.CrossRefGoogle Scholar
  7. 7.
    Specchio F, Saraceno R, Chimenti S, Nisticò S. Management of non-melanoma skin cancer in solid organ transplant recipients. Int J Immunopathol Pharmacol. 2014;27(1):21–4.  https://doi.org/10.1177/039463201402700104.CrossRefPubMedGoogle Scholar
  8. 8.
    Specchio F, Carboni I, Chimenti S, Tamburi F, Nisticò S. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Int J Immunopathol Pharmacol. 2014;27(1):1–4.  https://doi.org/10.1177/039463201402700101.CrossRefPubMedGoogle Scholar
  9. 9.
    Bottoni U, Tiriolo R, Pullano S, Dastoli S, Amoruso G, Nistico S, Fiorillo A. Infrared saliva analysis of psoriatic and diabetic patients: similarities in protein components. IEEE Trans Biomed Eng. 2016 Feb;63(2):379–84.  https://doi.org/10.1109/TBME.2015.2458967.CrossRefPubMedGoogle Scholar
  10. 10.
    Chimento SM, Newland M, Ricotti C, Nistico S. Romanelli P. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo. J Drugs Dermatol. 2008;7(3):258–63.PubMedGoogle Scholar
  11. 11.
    Nisticò S, Saraceno R, Capriotti E, De Felice C, Chimenti S. Efficacy of monochromatic excimer light (308nm) for the treatment of atopic dermatitis in adults and children. Photomed Laser Surg. 2008;26(1):14–8.  https://doi.org/10.1089/pho.2017.2116.CrossRefPubMedGoogle Scholar
  12. 12.
    Cannarozzo G, Sannino M, Tamburi F, Chiricozzi A, Saraceno A, Morini C, Nisticò S. Deep pulse fractional CO2 laser combined with a radiofrequency system: results of a case series. Photomed Laser Surg. 2014;32(7):409–12.  https://doi.org/10.1089/pho.2014.3733.CrossRefPubMedGoogle Scholar
  13. 13.
    Mercuri SR, Brianti P, Dattola A, Bennardo L, Silvestri M, Schipani G, Nisticò SP. CO2 laser and photodynamic therapy: study of efficacy in periocular BCC. Dermatol Ther. 2018;31(4):e12616.  https://doi.org/10.1111/dth.12616.CrossRefPubMedGoogle Scholar
  14. 14.
    Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon. 2007;5:175–80.CrossRefGoogle Scholar
  15. 15.
    Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology. 2002;204:130–2.  https://doi.org/10.1159/000051830.CrossRefPubMedGoogle Scholar
  16. 16.
    Mancini RE, Quaife JV. Histogenesis of experimentally produced keloids. J Invest Dermatol. 1962;38:143–81.CrossRefGoogle Scholar
  17. 17.
    Chung S, Nakashima M, Zembutsu H, Nakamura G. Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:563–73.  https://doi.org/10.2183/pjab.87.563.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Cannarozzo G, Sannino M, Tamburi F, Morini C, Nisticò SP. Flash-lamp pulsed-dye laser treat-ment of keloids: results of an observational study. Photomed Laser Surg. 2015;33(5):274–7.  https://doi.org/10.1089/pho.2015.3895.CrossRefPubMedGoogle Scholar
  19. 19.
    Bernstein EF. The pulsed-dye laser for treatment of cutaneous conditions. G Ital Dermatol Venereol. 2009;144(5):557–72.PubMedGoogle Scholar
  20. 20.
    Cohen IK, Keiser HR, Sjoerdsmo A. Collagen synthesis in human keloid and hypertrophic scars. Surg Forum. 1971;22:488.PubMedGoogle Scholar
  21. 21.
    Urioste SS, Arndt KA, Dover JS. Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg. 1999;18:159–71.CrossRefGoogle Scholar
  22. 22.
    Topol BM, Lewis VL Jr, Benveniste K. The use of antihistamine to retard the growth of fibroblasts derived from human skin, scar and keloid. Plast Reconstr Surg. 1981;68:231–2.  https://doi.org/10.1097/00006534-198108000-00018.CrossRefGoogle Scholar
  23. 23.
    Kuo YR, Jeng SF, Wang FS, et al. Flashlamp pulsed dye lasers (PDL) suppression of keloid proliferation through down-regulation of TGFbeta1 expression and extracellular matrix expression. Lasers Surg Med. 2004;34:104–8.  https://doi.org/10.1002/lsm.10206.CrossRefPubMedGoogle Scholar
  24. 24.
    Holmes A, Abraham DJ, Sa S. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem. 2001;276:10594–1601.  https://doi.org/10.1074/jbc.M010149200.CrossRefPubMedGoogle Scholar
  25. 25.
    Nouri K, Jimenez GP, Harrison-Balestra C, Elgart GW. 585-nm pulsed dye laser in the treatment of surgical scars starting on the suture removal day. Dermatol Surg. 2003;29:65–73.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Giovanni Cannarozzo
    • 1
  • Steven Paul Nisticò
    • 2
  • Keyvan Nouri
    • 3
  • Mario Sannino
    • 1
  1. 1.Department of DermatologyUniversity of Rome Tor VergataRomeItaly
  2. 2.Department of Health ScienceMagna Graecia UniversityCatanzaroItaly
  3. 3.Department of Dermatology and Cutaneous SurgeryUniversity of Miami Leonard M. Miller School of MedicineMiamiUSA

Personalised recommendations